Japan Intellectual Property Rights: XBP1, CD138 AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THOSE PEPTIDES, AND METHODS OF USING SUCH PEPTIDES AND COMPOSITIONS

Japan, March 27 -- DANA FARBER CANCER INSTITUTE INC has got intellectual property rights for 'XBP1, CD138 AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THOSE PEPTIDES, AND METHODS OF USING SUCH PEPTIDES AND COMPOSITIONS.' Other related details are as follows:

Application Number: JP,2021-105587

Category (FI): A61K31/454,A61K31/713,A61K38/08,A61K38/19,A61K39/395@D,A61K39/395@N,A61K45/00,A61P35/00,A61P35/02,A61P37/04,A61P43/00,121,C07K14/47,C07K14/705,C07K16/18,C07K16/28,C07K7/06,C07K7/08

Stage: Grant (IP right granted following substantive examination.)

Filing Date: June 25, 2021

Publication Date: Sept. 30, 2021

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndic...